Clinical Trials Directory

Trials / Completed

CompletedNCT02090400

Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women

Multi-centre, Randomized, Open Label Trial to Evaluate the Effects of Switching to Bazedoxifene in Comparison With Switching to Calcium and Vitamin D in Postmenopausal Women Previously Treated With Bisphosphonates

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Instituto Palacios · Academic / Other
Sex
Female
Age
55 Years
Healthy volunteers
Accepted

Summary

The aim of this study is see the changes in bone mineral density after discontinuation or stop the use of bisphosphonates and make the switch to bazedoxifene).

Detailed description

The primary hypothesis is: "Comparing to control group (Calcium+VitD), Bazedoxifene group (20mg daily+ calcium+VitD) is efficient in reducing BMD in spine at 12 months of treatment. in postmenopausal women switching from daily, weekly or monthly bisphosphonates therapy. It is a non-inferiority study of Bazedoxifene compared to biphosphonates, being each patient its own control from the baseline. It is a superiority study of Bazedoxifene compared to Calcium+VitD. Taking into account the difference in the percentage change observed in the total BMD of the spine during 12 months in those patients treated with Bazedoxifene+Ca+VitD at least 110 patients should be included, 55 in each arm of treatment. This simple size is going to allow us to detect the differences in the percentage change observed in the total BMD of the spine during 12 months between the two treatment arms, being the same or over 0.25%, with a significance level of 95%, an 80% power. It is estimated a standard deviation of 0.5%, and a 10% lost follow-up rate.

Conditions

Interventions

TypeNameDescription
DRUGBazedoxifene20 mg Oral daily for 12 months
DRUGCalcium/Vit DCalcium 500 mg / 400 IU Vit D

Timeline

Start date
2013-05-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2014-03-18
Last updated
2015-09-09

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02090400. Inclusion in this directory is not an endorsement.